R&D News | pharmaphorum

News

The new pharma collaborations driving transformative research in oncology

Cancer Research UK partnership aims to back 10 new startups

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups.

News

Report finds UK risks falling behind rivals in life sciences

A just-published report on the UK's life sciences sector "ought to ring alarm bells across government," according to the Association of the British Pharmaceutical Industry (ABPI).<

News

Ex-GSK vaccine chief to lead new UK biotech Vicebio

GSK's former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncyti

News

Bid to expand Keytruda use in head and neck cancer therapy f...

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in

News

CAMP4 raises $100m to take lead RNA drugs into clinic

Armed with a $100 million second-round financing, CAMP4 Therapeutics is preparing to start the first clinical trial of a drug targeting regulatory RNA (regRNA) molecules that can be used to

News

UK scientists say they have found cancer driver in junk DNA

It has suspected for many years that some diseases may be linked to non-coding or 'junk' DNA, but the mechanism behind the pathology hasn't been worked out.

Cancer Research UK partnership aims to back 10 new startups

Report finds UK risks falling behind rivals in life sciences

Ex-GSK vaccine chief to lead new UK biotech Vicebio

Bid to expand Keytruda use in head and neck cancer therapy f...

CAMP4 raises $100m to take lead RNA drugs into clinic

UK scientists say they have found cancer driver in junk DNA

Moderna's Q1 revenues rocket, thanks to ex-US sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks